Corcept Therapeutics Incorporated (CORT) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by, and welcome to CourseUp Therapeutics first quarter, 2026 earnings conference call. Currently, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star-1-1 on your telephone. To remove yourself from the queue, you may press star-1-1 again. I would now like to hand the call over to Adubak Makari, CFO. Please, go ahead. Hello, everyone. Good afternoon, and thank you for joining us. Today, we issued a press release announcing our financial results for the first quarter and providing a corporate update. Copy is available at coursehub.com. Our complete financial results will be available when we file our Form 10-Q with the SEC. Today's call is being recorded. It will be available at the Investors Pass Events tab of our website. Statements during this call, other than statements of historical fact, are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties which might cause actual results to be materially different from those such statements express or imply. The risks and uncertainties that may affect our forward-looking statements are described in our annual report on Form 10-K and our quarterly reports on Form 10-Q, which are available at the SEC's website. Please refer to those documents for more information. We disclaim any intention or duty to update forward-looking statements. Our revenue in the first quarter of 2026 was $164.9 million, compared to $157.2 million in the prior year period. We have increased our 2026 revenue guidance to $950 million to $1.05 billion. Net loss was $31.8 million in the first quarter of 2026 compared to net income of $20.5 million ...